RecruitingNCT06416761

Genetics in the Progression of Nephropathies

The Genetic Contribution to Progression of Kidney Disease


Sponsor

Ospedale San Raffaele

Enrollment

10,000 participants

Start Date

May 19, 2006

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to: * AKI * CKD * Hypertension * ADPKD * CKD-MBD * Patients with decompensated heart failure undergoing either medical or surgery therapy * Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation * glomerular diseases


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how genetic factors affect the progression of kidney diseases (nephropathies). By analyzing the genetics of patients with kidney disease, researchers hope to better understand why some people's kidney disease worsens faster than others and identify new treatment targets. **You may be eligible if...** - You have been diagnosed with a specific kidney disease (as defined by the relevant sub-protocol for your condition) **You may NOT be eligible if...** - The specific exclusion criteria depend on which kidney disease sub-protocol applies to you — your doctor will review these with you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICgenetic polymorphisms

Locations(1)

IRCCS Ospedale San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06416761


Related Trials